Fralin Biomedical Research Institute: Neuroscientist Awarded Grant to Study Serotonin-Based Modulation to Treat Seizures
October 18, 2024
October 18, 2024
ROANOKE, Virginia, Oct. 18 (TNSres) -- The Fralin Biomedical Research Institute at Virginia Tech issued the following news:
* * *
Sharon Swanger, an assistant professor at the Fralin Biomedical Research Institute, will use a $200,000 grant from the commonwealth to study how an approved drug impacts a rare form of epilepsy called Dravet syndrome.
* * *
Dravet syndrome, a rare form of epilepsy that affects one in 15,000 people, is fatal to one in . . .
* * *
Sharon Swanger, an assistant professor at the Fralin Biomedical Research Institute, will use a $200,000 grant from the commonwealth to study how an approved drug impacts a rare form of epilepsy called Dravet syndrome.
* * *
Dravet syndrome, a rare form of epilepsy that affects one in 15,000 people, is fatal to one in . . .